Faculty

Marwan Haddad, MD, MPH, Medical Director of the Center for Key Populations at Community Health Center, Inc. Marwan Haddad is the Medical Director of the Center for Key Populations. He joined Community Health Center, Inc. in July 2006. He received his Bachelor of Arts degree from Harvard College and his medical degree from McGill University. He completed his family medicine residency at University of Toronto and obtained his Masters in Public Health from Johns Hopkins University. He is board certified in Family Medicine. He is certified by the American Academy of HIV Medicine as an HIV specialist. He was also the recipient of the 2011 Primary Care Leadership Award presented by the Connecticut Center for Primary Care. Dr. Haddad is an Assistant Clinical Professor of Family Medicine at Quinnipiac University. Since January 2012, Dr. Haddad has led the CHC Project ECHO HIV, Hepatitis C, and Buprenorphine programs which expand the integration of these programs not only within CHC but nationwide. This model of care utilizes didactic and case-based learning via video conferences with medical providers, offering ongoing support, consultation and guidance to aid in delivering care to the HIV, Hepatitis C, and opioid using populations. In 2021, Dr. Haddad was named Chair of the HIV Medicine Association. Moreover, Dr. Haddad has taught and lectured at state and national conferences on HIV, Hepatitis C, medication assisted treatment and substance use management, and integrated care. He has published research on the integration of medication assisted treatment such as buprenorphine in community health centers examining both substance use as well as primary care outcomes.

Weitzman Institute Disclosure Statement

It is the policy of the Weitzman Institute to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the Weitzman Institute requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Faculty participating in a Weitzman Institute-sponsored activity must disclose to the planning committee and audience all financial or other relationship(s) with ineligible companies.

Faculty Disclosures

No faculty disclosed a relevant financial relationship for this program.